Inovio Pharmaceuticals, Inc. - stock earnings
INO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -33.9 million USD | 388446 USD |
2023Q2 | -35.5 million USD | 225971 USD |
2023Q1 | 2.9 billion USD | 114943 USD |
2022Q4 | -51.7 million USD | 124666 USD |
2022Q3 | -39.6 million USD | 9.2 million USD |
2022Q2 | -112.5 million USD | 784395 USD |
2022Q1 | -83.9 million USD | 199074 USD |
2021Q4 | -106.9 million USD | 839115 USD |
2021Q3 | -60.2 million USD | 291698 USD |
2021Q2 | -82.1 million USD | 272824 USD |
2021Q1 | -54.4 million USD | 371120 USD |
2020Q4 | -24.3 million USD | 5.6 million USD |
2020Q3 | 19.2 million USD | 236178 USD |
2020Q2 | -128.7 million USD | 267187 USD |
2020Q1 | -32.5 million USD | 1.3 million USD |
2019Q4 | -37.7 million USD | 279488 USD |
2019Q3 | -23.1 million USD | 866863 USD |
2019Q2 | -29.4 million USD | 135673 USD |
2019Q1 | -29.2 million USD | 2.8 million USD |
2018Q4 | -33.0 million USD | 2.5 million USD |
2018Q3 | -25.0 million USD | 2.0 million USD |
2018Q2 | -6.6 million USD | 24.4 million USD |
2018Q1 | -32.4 million USD | 1.5 million USD |
2017Q4 | -21.5 million USD | 8.8 million USD |
2017Q3 | -34.1 million USD | 2.6 million USD |
2017Q2 | -9.5 million USD | 20.4 million USD |
2017Q1 | -23.1 million USD | 10.4 million USD |
2016Q4 | -26.2 million USD | 8.5 million USD |
2016Q3 | -20.8 million USD | 12.5 million USD |
2016Q2 | -18.7 million USD | 6.2 million USD |
2016Q1 | -8.0 million USD | 8.1 million USD |
2015Q4 | -18.0 million USD | 5.9 million USD |
2015Q3 | 5.6 million USD | 24.2 million USD |
2015Q2 | -6.2 million USD | 5.3 million USD |
2015Q1 | -10.6 million USD | 5.2 million USD |
2014Q4 | -7.4 million USD | 2.5 million USD |
2014Q3 | -7.2 million USD | 1.8 million USD |
2014Q2 | -10.7 million USD | 3.8 million USD |
2014Q1 | -10.8 million USD | 2.4 million USD |
2013Q4 | -15.5 million USD | 1.7 million USD |
2013Q3 | -30.9 million USD | 9.5 million USD |
2013Q2 | -10.9 million USD | 785610 USD |
2013Q1 | -8.8 million USD | 1.5 million USD |
2012Q4 | -658751 USD | 1.1 million USD |
2012Q3 | -6.6 million USD | 854696 USD |
2012Q2 | -4.1 million USD | 436082 USD |
2012Q1 | -8.3 million USD | 1.7 million USD |
2011Q4 | -5.5 million USD | 1.6 million USD |
2011Q3 | -4.5 million USD | 2.6 million USD |
2011Q2 | -2.8 million USD | 2.4 million USD |
2011Q1 | -2.4 million USD | 3.1 million USD |
2010Q4 | -6.3 million USD | 2.4 million USD |
2010Q3 | -1.4 million USD | 1.3 million USD |
2010Q2 | -7.6 million USD | 1.1 million USD |
2010Q1 | -2.3 million USD | 1.4 million USD |
2009Q4 | -7.3 million USD | 2.6 million USD |
2009Q3 | -2.9 million USD | 3.6 million USD |
2009Q2 | -10.7 million USD | 2.5 million USD |
2009Q1 | -3.5 million USD | 369450 USD |
2008Q4 | -3.6 million USD | 326847 USD |
2008Q3 | -2.3 million USD | 454737 USD |
2008Q2 | -4.0 million USD | 663034 USD |
2008Q1 | -3.0 million USD | 653014 USD |
2007Q4 | 2.0 million USD | 3.3 million USD |
2007Q3 | -4.6 million USD | 486511 USD |
2007Q2 | -4.5 million USD | 495577 USD |
2007Q1 | -4.1 million USD | 503902 USD |
2006Q4 | -3.4 million USD | 1.5 million USD |
2006Q3 | -3.4 million USD | 575829 USD |
2006Q2 | -3.0 million USD | 662690 USD |
2006Q1 | -2.6 million USD | 697993 USD |
2005Q4 | -3.0 million USD | 829237 USD |
2005Q3 | -3.0 million USD | 724480 USD |
2005Q2 | -2.1 million USD | 3.0 million USD |
2005Q1 | -7.1 million USD | 961921 USD |
2004Q4 | -3.8 million USD | 542738 USD |
2004Q3 | -3.4 million USD | 455157 USD |
2004Q2 | -2.2 million USD | 99819 USD |
2004Q1 | -1.6 million USD | 69385 USD |
2003Q4 | -1.8 million USD | 38077 USD |
2003Q3 | -1.7 million USD | 22311 USD |
2003Q2 | -1.4 million USD | 9004 USD |
2003Q1 | 178048 USD | 11137 USD |
2002Q4 | -1.6 million USD | 76193 USD |
2002Q3 | -1.4 million USD | 67887 USD |
2002Q2 | -1.5 million USD | 40971 USD |
2002Q1 | -7.2 million USD | 1.0 million USD |
2001Q4 | -2.7 million USD | 1.3 million USD |
2001Q3 | -1.7 million USD | 1.3 million USD |
2001Q2 | -2.7 million USD | 837722 USD |
2001Q1 | -2.7 million USD | 1.3 million USD |
2000Q4 | -2.2 million USD | 1.2 million USD |
2000Q3 | -1.9 million USD | 1.4 million USD |
2000Q2 | -1.9 million USD | 1.3 million USD |
2000Q1 | -2.4 million USD | 1.5 million USD |
1999Q4 | -2.0 million USD | 1.3 million USD |
1999Q3 | -2.2 million USD | 1.5 million USD |
1999Q2 | -2.9 million USD | 900000 USD |
1999Q1 | -2.6 million USD | 5.2 million USD |
1998Q4 | 1.0 million USD | 900000 USD |
INO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -164.6 million USD | 854025 USD |
2022 | -287.7 million USD | 10.3 million USD |
2021 | -305.4 million USD | 1.8 million USD |
2020 | -215.1 million USD | 7.4 million USD |
2019 | -120.6 million USD | 4.1 million USD |
2018 | -97.0 million USD | 30.5 million USD |
2017 | -88.2 million USD | 42.2 million USD |
2016 | -73.7 million USD | 35.4 million USD |
2015 | -29.2 million USD | 40.6 million USD |
2014 | -36.1 million USD | 10.5 million USD |
2013 | -66.0 million USD | 13.5 million USD |
2012 | -19.7 million USD | 4.1 million USD |
2011 | -15.3 million USD | 9.8 million USD |
2010 | -17.6 million USD | 6.1 million USD |
2009 | -24.4 million USD | 9.1 million USD |
2008 | -13.0 million USD | 2.1 million USD |
2007 | -11.2 million USD | 4.8 million USD |
2006 | -12.5 million USD | 3.5 million USD |
2005 | -15.3 million USD | 5.5 million USD |
2004 | -11.0 million USD | 1.2 million USD |
2003 | -4.7 million USD | 80529 USD |
2002 | -6.0 million USD | 189521 USD |
2001 | -8.9 million USD | 4.5 million USD |
2000 | -8.6 million USD | 5.1 million USD |
1999 | -9.6 million USD | 5.1 million USD |
1998 | -6.6 million USD | 8.3 million USD |
INO
Price: $12.10
52 week price:
Earnings Per Share: -6.09 USD
P/E Ratio: -0.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.8 million
Ebitda: -28.0 millionMarket Capitalization: 269.0 million